We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Start-Ups To Once Again Play Starring Role at MEDICA 2024

By LabMedica International staff writers
Posted on 07 Nov 2024

The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62 countries from Armenia to China and America to Rwanda. More...

They will be exhibiting their innovative solutions on the MEDICA INNOVATION FORUM stage as part of MEDICA (Düsseldorf, Germany), the leading international trade fair for the healthcare and medical equipment industries to be held in Düsseldorf from 11 to 14 November 2024.

At the MEDICA INNOVATION FORUM alone, more than 120 luminaries – including global players such as Microsoft, HP, HTC, 3M, Roche, Huawei, and KUKA – will be showcasing and discussing groundbreaking innovations and best practices. Key topics will include generative AI and big data, robotics, XR and digital twins, mobile health and medical wearables, 3D printing, the Internet of Medical Things and solutions for the hospitals of the future. The MEDICA INNOVATION FORUM will also provide a meeting place and networking platform, “Women Leaders in Healthcare.” With this year’s record participation of 60 young businesses, the MEDICA START-UP PARK will be offering visiting professionals the opportunity to familiarize themselves with a host of other exciting health start-ups and their innovations.

This year’s top 12 health techpreneurs will be presenting their solutions in the pitch final at the 16th Healthcare Innovation World Cup. This will take place on stage at the MEDICA INNOVATION FORUM, where speakers will showcase the next generation of smart health devices, medical wearables, XR solutions, digital biomarkers, electroceuticals, and smart bandages. Finalists Saventic Health, U-Care Medical Srl, and IQONIC.AI are all in on artificial intelligence. Saventic uses AI to detect rare diseases, U-Care to improve clinical outcomes in intensive care units, and IQONIC.AI provides AI-supported dermatology solutions for analyzing skin conditions and issuing personalized treatment recommendations based on advanced imaging technology.

The robotics category will be represented in the final by Robota, Robeauté, and Goodbot. Specifically, Robeauté is supporting the medical profession by supplying neurosurgical micro-robots. Robota offers an automated system for sterilizing surgical instruments, while Goodbot provides an innovative pipetting robot. Doctorderma, Vertify GmbH, and PharmaTrail AG will present their health apps. PharmaTrail develops digital solutions to streamline and optimize clinical trial management to improve efficiency and data accuracy in pharmaceutical research. AGED Diagnostics, Fepod Oy Ltd., and Dxcover are focused on laboratory diagnostics. For example, Dxcover will present an innovative liquid biopsy technology for the early detection of cancer via a simple blood test.

At an exciting onstage program, 3D printing will be the subject of discussion, before attention turns to innovative prosthetics, orthotics, and similar applications. The future of therapy will also be the center of attention at the forum. The series of talks will run the gamut from digital tools for home patient care to robot-assisted surgery, rehabilitation, and assistive technologies. The final day at the MEDICA INNOVATION FORUM will include an international flavor, with healthcare hubs from Finland, France, Germany, Taiwan, and Japan presenting their organizations. This will also offer a perfect segue into the MEDICA START-UP PARK near the forum stage. In this space, start-ups from all over the world – including Germany, Italy, India, Japan, Taiwan, Switzerland, and the United States – will be putting their innovations for healthcare on show.

Related Links:
MEDICA


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.